1. Home
  2. RR vs RCKT Comparison

RR vs RCKT Comparison

Compare RR & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Richtech Robotics Inc. Class B

RR

Richtech Robotics Inc. Class B

SELL

Current Price

$1.47

Market Cap

375.9M

Sector

N/A

ML Signal

SELL

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

BUY

Current Price

$2.34

Market Cap

394.2M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
RR
RCKT
Founded
2016
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
375.9M
394.2M
IPO Year
2023
2014

Fundamental Metrics

Financial Performance
Metric
RR
RCKT
Price
$1.47
$2.34
Analyst Decision
Buy
Analyst Count
0
14
Target Price
N/A
★ $8.58
AVG Volume (30 Days)
★ 3.7M
2.1M
Earning Date
08-19-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 26.37
EPS
N/A
★ 0.66
Revenue
★ $5,045,000.00
N/A
Revenue This Year
$8.03
N/A
Revenue Next Year
$22.75
$915.60
P/E Ratio
★ N/A
$3.76
Revenue Growth
★ 18.99
N/A
52 Week Low
$1.30
$2.42
52 Week High
$7.00
$5.45

Technical Indicators

Market Signals
Indicator
RR
RCKT
Relative Strength Index (RSI) 38.13 28.13
Support Level $1.30 N/A
Resistance Level $1.79 $4.02
Average True Range (ATR) 0.08 0.17
MACD -0.02 -0.01
Stochastic Oscillator 4.84 2.86

Price Performance

Historical Comparison
RR
RCKT

About RR Richtech Robotics Inc. Class B

Richtech Robotics Inc is a robotics and artificial intelligence (AI) technology company focused on developing embodied AI systems that aims to improve the efficiency and productivity of businesses. The company trains proprietary artificial intelligence models on in-house data to operate robotic systems in the real world. It designs, engineers, manufactures, and deploys next generation embodied AI systems to serve a wide range of industries, including food service, retail, industrial manufacturing, automotive, healthcare, and hospitality. The company's offerings include Commercial Robotic Products, Industrial Robotic Products and Data Services. The company generated the majority of its revenue through product revenue (i.e. outright hardware sales).

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: